Purpose: Nanotechnologies turned out to be promising in the development of diagnostic and therapeutic approaches toward neurodegenerative disorders. However, only a very scant number of nanodevices until now proved to be effective on preclinical animal models. Although specific tests in vivo are available to assess the potential toxicity of these nanodevices on cognitive functions, those to evaluate their biosafety in vitro on neurons are still to be improved. Materials and methods: We utilized the patch-clamp technique on primary cultures of cortical neural cells isolated from neonatal rats, aiming to evaluate their electrical properties after the incubation with liposomes (mApoE-PA-LIPs), previously proved able to cross the blood–brain barrier and to be effective on mouse models of Alzheimer’s disease (AD), both in the absence and in the presence of β-amyloid peptide oligomers. Results: Data show a high degree of biocompatibility, evaluated by lactate dehydrogenase (LDH) release and MTT assay, and the lack of cellular internalization. After the incubation with mApoE-PA-LIPs, neuronal membranes show an increase in the input resistance (from 724.14±76 MΩ in untreated population to 886.06±86 MΩ in the treated one), a reduction in the rheobase current (from 29.6±3 to 24.2±3 pA in untreated and treated, respectively), and an increase of the firing frequency, consistent with an ultimate increase in intrinsic excitability. Data obtained after co-incubation of mApoE-PA-LIPs with β-amyloid peptide oligomers suggest a retention of liposome efficacy. Conclusion: These data suggest the ability of liposomes to modulate neuronal electrical properties and are compatible with the previously demonstrated amelioration of cognitive functions induced by treatment of AD mice with liposomes. We conclude that this electrophysiological approach could represent a useful tool for nanomedicine to evaluate the effect of nanoparticles on intrinsic neuronal excitability.
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of alzheimer’s disease / A. Binda, A. Panariti, A. Barbuti, C. Murano, R.D. Magro, M. Masserini, F. Re, I. Rivolta. - In: INTERNATIONAL JOURNAL OF NANOMEDICINE. - ISSN 1176-9114. - 13(2018), pp. 4059-4071.
|Titolo:||Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of alzheimer’s disease|
|Parole Chiave:||neurodegenerative disorders; nanomedicine; action potential; electrophysiology; patch clamp; beta-amyloid peptide|
|Settore Scientifico Disciplinare:||Settore BIO/09 - Fisiologia|
|Data di pubblicazione:||2018|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.2147/IJN.S161563|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|ijn-161563-modulation-of-the-intrinsic-neuronal-excitability-by-multifu-071018.pdf||Publisher's version/PDF||Open Access Visualizza/Apri|